Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,845 | -465,317 | -342,502 | -212,411 | -96,774 |
| Depreciation Amortization | -1,060 | -11,535 | -9,795 | -7,206 | -3,451 |
| Accounts receivable | -5,091 | -592 | N/A | N/A | 0 |
| Other Working Capital | -26,201 | 4,842 | -4,430 | -2,935 | -9,537 |
| Other Operating Activity | 35,494 | 94,680 | 71,706 | 48,249 | 21,310 |
| Operating Cash Flow | $-124,703 | $-377,922 | $-285,021 | $-174,303 | $-88,452 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -251,539 | 179,670 | 122,105 | -43,567 | -84,722 |
| PPE Investments | -820 | -5,762 | -5,304 | -4,441 | -1,239 |
| Investing Cash Flow | $-252,359 | $173,908 | $116,801 | $-48,008 | $-85,961 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 389,875 | 40,611 | 14,576 | 11,492 | 4,437 |
| Financing Cash Flow | $389,875 | $40,611 | $14,576 | $11,492 | $4,437 |
| Exchange Rate Effect | -8 | -106 | N/A | N/A | N/A |
| Beginning Cash Position | 102,336 | 265,845 | 265,845 | 265,845 | 265,845 |
| End Cash Position | 115,141 | 102,336 | 112,201 | 55,026 | 95,869 |
| Net Cash Flow | $12,805 | $-163,509 | $-153,644 | $-210,819 | $-169,976 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,703 | -377,922 | -285,021 | -174,303 | -88,452 |
| Capital Expenditure | -820 | -5,762 | -5,304 | -4,441 | -1,239 |
| Free Cash Flow | -125,523 | -383,684 | -290,325 | -178,744 | -89,691 |